Fibrinolytic and antithrombotic therapy theory, practice, and management /
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Kaituhi rangatōpū: | |
| Ētahi atu kaituhi: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Oxford ; New York :
Oxford University Press,
2006.
|
| Putanga: | 2nd ed. |
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- Historical perspectives in hemostasis, coagulation and fibrinolysis
- Vascular biology, thromboresistance and inflammation
- Atherosclerosis and arterial thrombosis
- Venous thromboembolism
- Cardiac chamber, aortic and valvular thromboembolism
- Fibrinolytic agents
- Aspirin
- Clopidogrel
- Platelet Glycoprotein IIb/IIIa receptor antagonists
- Aggrenox and cilostazol
- Novel platelet antagonists
- Combination pharmacotherapy
- Facilitated percutaneous coronary intervention
- Thrombin-directed therapy
- Factor Xa inhibitors
- Direct thrombin inhibitors
- Novel anticoagulants
- Acute coronary syndromes
- Peripheral vascular disease and stroke
- Valvular heart disease and atrial fibrillation
- Plaque-stabilizing therapies
- Venous thromboembolism prophylaxis
- Venous thromboembolism treatment
- Fundamentals and patient evaluation
- Platelet antagonists
- Anticoagulants
- Anticoagulation clinics and self-testing
- Platelet antagonists
- Anticoagulants
- Fibrinolytic agents.